{"id":149145,"date":"2021-10-13T13:15:00","date_gmt":"2021-10-13T13:15:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2930970"},"modified":"2021-10-13T13:15:00","modified_gmt":"2021-10-13T13:15:00","slug":"else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/","title":{"rendered":"Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula"},"content":{"rendered":"

\"4395<\/p>\n

Development brings Company a step closer to bringing first-of-its-kind product to $90 Billion Global Infant Formula Market.<\/p>\n

VANCOUVER, BC , October 13, 2021 – ELSE NUTRITION HOLDINGS INC. (<\/strong>BABY.V<\/strong><\/a>) (<\/strong>BABYF<\/strong><\/a>) (<\/strong>0YL.F<\/strong><\/a>) (“Else” <\/strong>or the “Company”)<\/strong> the Plant-Based baby, toddler and children nutrition company<\/a>, today announced that is has successfully completed its first commercial trial run of its patented, Plant-Based Infant Formula for age 0 -12 months as the Company continues its path for regulatory approval.<\/p>\n

The trial run, which took place this week in the U.S., leveraged a global, first-of-its kind technological development with one of the raw ingredients in the Plant-Based formulation. This patented processing method results in a cleaner ingredient, while keeping the nutritional value fully intact.<\/p>\n

\u201cThis successful trial is a major step for the Company, as we move forward to provide real choice when it comes to dairy-free infant formula,\u201d said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. \u201cThe $90 billion global infant formula market has been dominated by dairy and soy for too long. This development brings us one step closer to commercializing a minimally processed, Plant-Based option to millions of wanting families globally,\u201d she added.<\/p>\n

\u00a0<\/strong><\/p>\n

About Else Nutrition Holdings Inc. <\/strong><\/p>\n

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s\u00a0Executives include leaders hailing from\u00a0leading infant nutrition companies. Many of Else advisory board\u00a0 members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,\u00a0 and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.<\/p>\n

For more information, visit:\u00a0elsenutrition.com<\/a>\u00a0or @elsenutrition on Facebook and Instagram.<\/p>\n

 <\/p>\n

Media Contact<\/strong><\/p>\n

Callie Rapp
\nBrilliant PR
\nCallier@brilliantprm.com<\/p>\n

 <\/p>\n

For more information, contact:<\/strong><\/p>\n

Mrs. Hamutal Yitzhak, CEO, Co-Founder & Director
\nELSE Nutrition Holdings Inc.
\nE: hamutaly@elsenutrition.com<\/a>
\nP: +972(0)3-6445095
\nMr. Sokhie Puar, Lead Director of Else Nutrition
\nEmail:\u00a0 sokhiep@elsenutrition.com<\/a>
\nP\u00a0: 604-603-7787<\/p>\n

 <\/p>\n

US Investor Relations Contact<\/strong><\/p>\n

Lytham Partners, LLC
\nMr. Ben Shamsian
\nNew York | Phoenix
\nEmail: shamsian@lythampartners.com<\/a>
\nP : 646-829-9701<\/p>\n

 <\/p>\n

TSX Venture Exchange<\/em><\/strong><\/p>\n

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/em><\/p>\n

\u00a0<\/em><\/p>\n

Caution Regarding Forward-Looking Statements<\/em><\/strong><\/p>\n

This press release contains statements that may constitute \u201cforward-looking statements\u201d within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as \u201cwill\u201d or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company\u2019s financial disclosure documents.\u00a0 Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management\u2019s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. \u00a0Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.\u00a0 Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management\u2019s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.<\/em><\/p>\n

Tags: Nutrition<\/a>, nutrition company<\/a>, nutrition for children<\/a>, plant based nutrition<\/a>, nutrition for toddlers.<\/a>, BABY.V<\/a>, BABYF<\/a>, 0YL.F<\/a>, Walmart.com<\/a>, Else Nutrition Holdings Inc<\/a>, Plant-Based Infant Formula<\/a> <\/p>\n

See Campaign: <\/strong>https:\/\/elsenutrition.com\/<\/a>
Tags:<\/b>
Menafn<\/a>, IPS<\/a>, Reportedtimes<\/a>, Google News<\/a>, Financial Content<\/a>, PR-Wirein<\/a>, ReleaseLive<\/a>, Extended Distribution<\/a>, iCN Internal Distribution<\/a>, English<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Development brings Company a step closer to bringing first-of-its-kind product to $90 Billion Global Infant Formula Market. VANCOUVER, BC , October 13, 2021 – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, today announced that is has successfully completed its first commercial trial run […] Continue Reading →<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-149145","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"\nElse Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula - Business\" \/>\n<meta property=\"og:description\" content=\"Development brings Company a step closer to bringing first-of-its-kind product to $90 Billion Global Infant Formula Market. VANCOUVER, BC , October 13, 2021 – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, today announced that is has successfully completed its first commercial trial run […] Continue Reading →\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-13T13:15:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/10\/4395-logoo20Else20Nutrition-2.jpg\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/\",\"name\":\"Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/10\/4395-logoo20Else20Nutrition-2.jpg\",\"datePublished\":\"2021-10-13T13:15:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/10\/4395-logoo20Else20Nutrition-2.jpg\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/10\/4395-logoo20Else20Nutrition-2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/","og_locale":"en_US","og_type":"article","og_title":"Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula - Business","og_description":"Development brings Company a step closer to bringing first-of-its-kind product to $90 Billion Global Infant Formula Market. VANCOUVER, BC , October 13, 2021 – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, today announced that is has successfully completed its first commercial trial run […] Continue Reading →","og_url":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/","og_site_name":"Business","article_published_time":"2021-10-13T13:15:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/10\/4395-logoo20Else20Nutrition-2.jpg","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/","url":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/","name":"Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/10\/4395-logoo20Else20Nutrition-2.jpg","datePublished":"2021-10-13T13:15:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/10\/4395-logoo20Else20Nutrition-2.jpg","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/10\/4395-logoo20Else20Nutrition-2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/10\/13\/else-nutrition-successfully-completes-first-production-trial-run-of-its-novel-plant-based-infant-formula\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/149145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=149145"}],"version-history":[{"count":8,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/149145\/revisions"}],"predecessor-version":[{"id":149611,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/149145\/revisions\/149611"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=149145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=149145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=149145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}